---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-22-000030"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:15:21.112142+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prestige Q2 revenue $289.3M (+4.7% YoY), EPS $1.02; reaffirms FY2023 outlook

## Summary
- Record Q2 revenue $289.3M (+4.7% YoY, +5.5% ex-currency); diluted EPS $1.02, ahead of expectations.
- International OTC segment revenue $37.2M (+51.9% YoY) driven by Hydralyte demand.
- Reduced debt by $35M; leverage ratio 3.7x; completed $50M share repurchase program.
- Reaffirms FY2023 outlook: revenue $1.12-1.13B, diluted EPS $4.18-4.23, FCF $260M+.

## SEC filing metadata
- accession: 0001295947-22-000030
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000030/0001295947-22-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000030/pbh-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-22-000030
- JSON: https://secwatch.observer/filing/0001295947-22-000030.json
- Plain text: https://secwatch.observer/filing/0001295947-22-000030.txt

## Key facts
- Earnings Releases
  Prestige Consumer Healthcare Inc. reported the fiscal quarter and six months ended September 30, 2022 results: revenue $289.3 million, net income $51.0 million, EPS $1.02. Guidance reaffirmed.
  - Period: the fiscal quarter and six months ended September 30, 2022
  - Revenue: $289.3 million
  - Net income: $51.0 million
  - EPS: $1.02
  - Guidance: reaffirmed
  - Result: reported results
  source text: herein by reference. --- EX-99.1 (EX-99.1) --- Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023 ◦ Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding Currency ◦ Diluted EPS of $1.02 for Q2, ahead of expectations ◦ Reduced Debt by $35 million in Q2 and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000030/0001295947-22-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.